Concepedia

Dvorit Samid

DS

Statistics

Publications

53

Citations

5.3K

H-Index

32

Active since

1984

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Uniformed Services University of the Health Sciences

University of Virginia

Johns Hopkins University

Dvorit Samid is an author at National Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1984–2005

53

Publications

53

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

James G. Herman, Farida Latif, Y Weng et al. · Proceedings of the National Academy of Sciences · 1994 · 1.5K citations · Full text

, , +16

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

, , +11

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Jeffrey S. Weber, Michael L. Salgaller, Dvorit Samid et al. · PubMed · 1994 · 296 citations

, , +17

Cinnamic acid: A natural product with potential use in cancer intervention

Lei Liu, W. Robert Hudgins, Sonsoles Shack et al. · International Journal of Cancer · 1995 · 193 citations

, , +11

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Alain Thibault, Michael R. Cooper, William D. Figg et al. · PubMed · 1994 · 157 citations

, , +13

1–5 of 53